Kelly R. Magliocca
Papers
4
Total Citations
63
H-Index
3
About
Dr. Kelly R. Magliocca is a leading head and neck pathologist whose research focuses on refining the diagnosis and treatment of oropharyngeal squamous cell carcinoma (OPSCC), particularly human papillomavirus (HPV)-associated disease. Her work critically evaluates the accuracy of preoperative imaging, demonstrating in a highly cited 2018 study (37 citations) that radiographic assessment cannot reliably predict macroscopic extranodal extension, challenging conventional staging paradigms. Dr. Magliocca has pioneered the use of narrowband imaging to identify unknown primary tumors prior to transoral robotic surgery (TORS), improving diagnostic precision. Her investigations into surgical margins have shown that revising positive specimen margins to negative does not compromise local control in HPV-mediated cancers. Notably, her 2021 study on 59 patients found that omitting intentional primary site radiation after TORS resulted in no locoregional failures, supporting de-escalation strategies to reduce treatment toxicity. With a cumulative impact of over 60 citations from her most influential works, Dr. Magliocca’s contributions are shaping more personalized, less morbid approaches to oropharyngeal cancer care, directly benefiting patients and guiding clinical decision-making.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4